4/6/2022
RedChip Logo RedChip Companies
Weekly Newsletter
 
 

Rail Vision Ltd. Announces Closing of Initial Public Offering

 

Rail Vision Ltd. (Nasdaq: RVSN), a development stage technology company that is seeking to revolutionize railway safety and the data-related market, announced the closing of its initial public offering of 3,787,241 ordinary shares and accompanying warrants to purchase 3,787,241 ordinary shares. Each ordinary share was sold together with one warrant to purchase one ordinary share with an exercise price of $4.13 at a combined public offering price of $4.13 per share and accompanying warrant. Gross proceeds for the offering were approximately $15.6 million, before deducting underwriting discounts and commissions and estimated offering expenses.

The Company granted Aegis Capital Corp, the underwriter, a 45-day over-allotment option to purchase additional ordinary shares and/or warrants to purchase additional ordinary shares up to 15% of the number of ordinary shares and warrants, respectively, sold in the offering solely to cover over-allotments, if any. On April 4, 2022, Aegis partially exercised its over-allotment option with respect to 568,086 warrants to purchase ordinary shares.

For more information, visit www.railvision.io

 
Read Full Release
 
 
 

SPI Energy Reports Record Revenue of $162 Million for 2021

SPI Energy Co., Ltd., (NASDAQ:SPI), a global renewable energy company and provider of solar storage and electric vehicle (EV) solutions announced its financial results for the fiscal year ended December 31, 2021. Net sales were $162.0 million in 2021, up 16.9% from $138.6 million in 2020, while total assets increased to $228.8 million, up 5.4% from $217.0 million in 2020. Cash and cash equivalents totaled $9.8 million as of December 31, 2021

 
Learn More
 

DeFi Technologies Announces Fiscal 2021 Financial Results with Total Revenue Up 411% Year-over-Year to $15.1M

DeFi Technologies Inc. (NEO: DEFI) (GR: RMJR) (OTC: DEFTF), a technology company bridging the gap between traditional capital markets and decentralized finance, announced its strong financial performance for the three and twelve-month period ending December 31, 2021. Key highlights included: Achieving US$363 million in assets under management ("AUM") in fully owned subsidiary Valour Inc., which is responsible for the company's portfolio of exchange-traded products ("ETPs"); Valour Inc., listed its Bitcoin Zero and Ethereum Zero ETPs on the Boerse Frankfurt Zertifikate AG ("Frankfurt Exchange"); Launched world's first Uniswap ETP on the Nordic Growth Market ("NGM") and the Frankfurt Exchange; and more.

 
Learn More
 

1847 Holdings Announces Fiscal Year 2021 Financial Results with Proforma Revenue Up 23.5%

1847 Holdings LLC (OTCQB: EFSH), a publicly traded holding company platform that combines the attractive attributes of private, lower-middle market businesses with the liquidity and transparency of a publicly traded company, announced financial results for its fiscal year ended December 31, 2021, highlighting a proforma revenue of $51.5 million for the year ended December 31, 2021, a 23% improvement from 2020’s proforma revenue of $41.7 million.

 
Learn More
 

EVmo Reports Record Revenue of $10.2M for 2021, Up 34.3% Over 2020

EVmo, Inc. (OTC: YAYO), a leading provider of vehicles to the rideshare and delivery gig economy industry, announced financial results for its fourth quarter and fiscal year ended December 31, 2021, featuring record revenue of $10.2 million, up 34.3% over 2020 revenue of $7.6M. The company also reported: Entering into a $15 million debt facility in July 2021; securing non-dilutive financing in March 2022 to support addition of 400 vehicles quarterly to Company’s fleet; and the launch of the industry’s first integrated gig delivery technology platform.

 
Learn More
 

 
 
Upcoming Events
7
April
2022
NASDAQ: NTWK - NETSOL Technologies
4:15pm Eastern
NETSOL Technologies is a global fintech and IT company with domain expertise in the leasing and financing industries. The Company's suite of applications are backed by 40 years of domain expertise and supported by a committed team of 1,300+ professionals placed in eight strategically located support and delivery centers throughout the world.
 
Sign Up
 
12
April
2022
NASDAQ: MDGS - Medigus Ltd
11:00am Eastern
Medigus Ltd is an Israel-based medical device company. It is engaged in the development, manufacturing, and marketing of surgical endostaplers and direct vision systems for minimally invasive medical procedures.
 
Sign Up
 
13
April
2022
NASDAQ: SVFD - Save Foods
4:15pm Eastern
Save Foods Inc and its Israeli subsidiary Save Foods Ltd are innovative, dynamic companies dedicated to delivering integrated eco-friendly solutions for improved safety, freshness and quality, every step of the way from field to fork.
 
Sign Up
 
14
April
2022
NASDAQ: LTRN - Lantern Pharma
4:15pm Eastern
Lantern Pharma is a clinical stage oncology-focused company who is harnessing the power of Artificial Intelligence and Genomics to develop precision cancer therapies. By leveraging RADR®, Lantern's proprietary big data engine, more effective cancer treatments can be developed and delivered to the right group of patients at a faster rate and for a fraction of the cost.
 
Sign Up
 
 
 
Archive Events
31
March
2022
OTC: DEFTF - DeFi Technologies
Meeting Duration 41 minutes
DeFi Technologies builds and manages assets in the rapidly emerging decentralized financial market, providing institutional and retail investors easy access to previously unseen returns through innovative projects and groundbreaking protocols that are fundamentally reshaping the global financial system.
 
Watch Replay
 
30
March
2022
NYSE American: DSS - DSS Inc.
Meeting Duration 28 minutes
DSS Inc. a global multinational company, operates businesses focused on brand protection technology, blockchain security, direct marketing, healthcare, real estate, and securitized digital assets
 
Watch Replay
 
29
March
2022
NASDAQ: CDTX - Cidara Therapeutics
Meeting Duration 27 minutes
Cidara is developing long-acting therapeutics designed to improve the standard of care for patients facing serious diseases. The Company’s portfolio is comprised of drug candidates intended to transform existing treatment and prevention paradigms.
 
Watch Replay
 
 
 

Lesson of the Week

Benefit from dollar cost averaging by building positions over time.

 
Learn More
 
 
 
RedChip Videos
Watch Now
Watch Now
Watch Now
Watch Now

 
 

MidSouth Week in Review

The S&P was down 4.9% during the first quarter of the year, its worst decline in two years.

 
Learn More
 
You are receiving this email because your email is subscribed to our mailing list.
Click here to unsubscribe your email address from this list.
Copyright © 2022. All rights reserved.
© 2022 RedChip , All rights reserved